FIELD: medicine, pharmacy, drugs. SUBSTANCE: invention relates to preparing the well tolerated preserved injection or infusion solution containing human protein. EFFECT: improved method of preparing. 11 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION REGULATING HEMATOPOIESIS | 1991 |
|
RU2100032C1 |
| METHOD FOR PRODUCING ERYTHROPOIETIN FORMS USEABLE FOR INJECTIONS | 1988 |
|
RU2043118C1 |
| NUCLEOSIDE PHOSPHOLIPID DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1991 |
|
RU2104282C1 |
| AGENT FOR COLORIMETRIC DETERMINATION OF ANALYTE | 1989 |
|
RU2015513C1 |
| PHARMACEUTICAL PREPARATION CONTAINING PLASMINOGEN ACTIVATORS | 1995 |
|
RU2155067C2 |
| DNA FRAGMENT CODING POLYPEPTIDE K2P WITH PLASMINOGEN ACTIVATOR PROPERTIES, POLYPEPTIDE K2P WITH PLASMINOGEN ACTIVATOR PROPERTIES, RECOMBINANT PLASMIDA DNA PA27 | 1990 |
|
RU2107094C1 |
| ENZYME IMMOBILIZED ON CARRIER AND METHOD OF ITS PREPARING | 1994 |
|
RU2135582C1 |
| METHOD OF PRODUCING DERIVATIVES OF RESORUPHINE | 0 |
|
SU1621811A3 |
| METHOD OF FINDING OF POLYVALENT ANTIGEN IN BIOLOGICAL FLUID | 1989 |
|
RU2032906C1 |
| METHOD OF SYNTHESIS OF 3- (HEXADECANESULFONYL- OR SULFINYL -2- METHOXYMETHYLPROPYL) -(2- TRIMETHYLAMMONIO-ETHYL) -PH- OSPHATE, THEIR STEREOISOMERS OR PHARMACOLOGICALLY ACCEPTIBLE SALTS | 1990 |
|
RU2035466C1 |
